Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:businessModel |
gptkb:public_company
|
| gptkbp:CEO |
gptkb:Patrick_Amstutz
|
| gptkbp:collaboratedWith |
gptkb:Allergan
gptkb:Amgen gptkb:Novartis |
| gptkbp:country |
gptkb:Switzerland
|
| gptkbp:focusesOn |
infectious diseases
oncology immuno-oncology |
| gptkbp:founded |
2004
|
| gptkbp:founder |
gptkb:Andreas_Plückthun
gptkb:Christian_Zahnd gptkb:Patrick_Amstutz |
| gptkbp:headquarters_location |
gptkb:Zurich
|
| https://www.w3.org/2000/01/rdf-schema#label |
Molecular Partners AG
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:SIX_Swiss_Exchange
|
| gptkbp:notableProduct |
gptkb:ensovibep
|
| gptkbp:numberOfEmployees |
~140 (2023)
|
| gptkbp:specializesIn |
gptkb:DARPin_therapeutics
protein therapeutics |
| gptkbp:stockExchange |
gptkb:SIX_Swiss_Exchange
|
| gptkbp:stockSymbol |
gptkb:MOLN
|
| gptkbp:website |
https://www.molecularpartners.com/
|
| gptkbp:bfsParent |
gptkb:designed_ankyrin_repeat_proteins_(DARPins)
|
| gptkbp:bfsLayer |
7
|